150 related articles for article (PubMed ID: 27547819)
1. Structure of the Essential
Kuhn ML; Alexander E; Minasov G; Page HJ; Warwrzak Z; Shuvalova L; Flores KJ; Wilson DJ; Shi C; Aldrich CC; Anderson WF
ACS Infect Dis; 2016 Aug; 2(8):579-591. PubMed ID: 27547819
[TBL] [Abstract][Full Text] [Related]
2. The dual function of the Mycobacterium tuberculosis FadD32 required for mycolic acid biosynthesis.
Léger M; Gavalda S; Guillet V; van der Rest B; Slama N; Montrozier H; Mourey L; Quémard A; Daffé M; Marrakchi H
Chem Biol; 2009 May; 16(5):510-9. PubMed ID: 19477415
[TBL] [Abstract][Full Text] [Related]
3. The acyl-AMP ligase FadD32 and AccD4-containing acyl-CoA carboxylase are required for the synthesis of mycolic acids and essential for mycobacterial growth: identification of the carboxylation product and determination of the acyl-CoA carboxylase components.
Portevin D; de Sousa-D'Auria C; Montrozier H; Houssin C; Stella A; Lanéelle MA; Bardou F; Guilhot C; Daffé M
J Biol Chem; 2005 Mar; 280(10):8862-74. PubMed ID: 15632194
[TBL] [Abstract][Full Text] [Related]
4. Ser/Thr Phosphorylation Regulates the Fatty Acyl-AMP Ligase Activity of FadD32, an Essential Enzyme in Mycolic Acid Biosynthesis.
Le NH; Molle V; Eynard N; Miras M; Stella A; Bardou F; Galandrin S; Guillet V; André-Leroux G; Bellinzoni M; Alzari P; Mourey L; Burlet-Schiltz O; Daffé M; Marrakchi H
J Biol Chem; 2016 Oct; 291(43):22793-22805. PubMed ID: 27590338
[TBL] [Abstract][Full Text] [Related]
5. Assay development for identifying inhibitors of the mycobacterial FadD32 activity.
Galandrin S; Guillet V; Rane RS; Léger M; N R; Eynard N; Das K; Balganesh TS; Mourey L; Daffé M; Marrakchi H
J Biomol Screen; 2013 Jun; 18(5):576-87. PubMed ID: 23364516
[TBL] [Abstract][Full Text] [Related]
6. Insight into Structure-Function Relationships and Inhibition of the Fatty Acyl-AMP Ligase (FadD32) Orthologs from Mycobacteria.
Guillet V; Galandrin S; Maveyraud L; Ladevèze S; Mariaule V; Bon C; Eynard N; Daffé M; Marrakchi H; Mourey L
J Biol Chem; 2016 Apr; 291(15):7973-89. PubMed ID: 26900152
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of FadD32, an enzyme essential for mycolic acid biosynthesis in mycobacteria.
Li W; Gu S; Fleming J; Bi L
Sci Rep; 2015 Dec; 5():15493. PubMed ID: 26628098
[TBL] [Abstract][Full Text] [Related]
8. In Silico Drug Repurposing Approach: Investigation of
Ngidi NTP; Machaba KE; Mhlongo NN
Molecules; 2022 Jan; 27(3):. PubMed ID: 35163931
[No Abstract] [Full Text] [Related]
9. The Pks13/FadD32 crosstalk for the biosynthesis of mycolic acids in Mycobacterium tuberculosis.
Gavalda S; Léger M; van der Rest B; Stella A; Bardou F; Montrozier H; Chalut C; Burlet-Schiltz O; Marrakchi H; Daffé M; Quémard A
J Biol Chem; 2009 Jul; 284(29):19255-64. PubMed ID: 19436070
[TBL] [Abstract][Full Text] [Related]
10. AcpM, the meromycolate extension acyl carrier protein of Mycobacterium tuberculosis, is activated by the 4'-phosphopantetheinyl transferase PptT, a potential target of the multistep mycolic acid biosynthesis.
Zimhony O; Schwarz A; Raitses-Gurevich M; Peleg Y; Dym O; Albeck S; Burstein Y; Shakked Z
Biochemistry; 2015 Apr; 54(14):2360-71. PubMed ID: 25785780
[TBL] [Abstract][Full Text] [Related]
11. Structure-function analysis of the acyl carrier protein synthase (AcpS) from Mycobacterium tuberculosis.
Dym O; Albeck S; Peleg Y; Schwarz A; Shakked Z; Burstein Y; Zimhony O
J Mol Biol; 2009 Nov; 393(4):937-50. PubMed ID: 19733180
[TBL] [Abstract][Full Text] [Related]
12. Diarylcoumarins inhibit mycolic acid biosynthesis and kill Mycobacterium tuberculosis by targeting FadD32.
Stanley SA; Kawate T; Iwase N; Shimizu M; Clatworthy AE; Kazyanskaya E; Sacchettini JC; Ioerger TR; Siddiqi NA; Minami S; Aquadro JA; Grant SS; Rubin EJ; Hung DT
Proc Natl Acad Sci U S A; 2013 Jul; 110(28):11565-70. PubMed ID: 23798446
[TBL] [Abstract][Full Text] [Related]
13. Crystal structures of FadD32 and pks13-ACP domain from Corynebacterium diphtheriae.
Chen R; Yuan J; Shi X; Tang W; Liu X
Biochem Biophys Res Commun; 2022 Jan; 590():152-157. PubMed ID: 34974304
[TBL] [Abstract][Full Text] [Related]
14. Protein-protein interactions within the Fatty Acid Synthase-II system of Mycobacterium tuberculosis are essential for mycobacterial viability.
Veyron-Churlet R; Guerrini O; Mourey L; Daffé M; Zerbib D
Mol Microbiol; 2004 Dec; 54(5):1161-72. PubMed ID: 15554959
[TBL] [Abstract][Full Text] [Related]
15. The biosynthesis of mycolic acids in Mycobacterium tuberculosis relies on multiple specialized elongation complexes interconnected by specific protein-protein interactions.
Veyron-Churlet R; Bigot S; Guerrini O; Verdoux S; Malaga W; Daffé M; Zerbib D
J Mol Biol; 2005 Nov; 353(4):847-58. PubMed ID: 16213523
[TBL] [Abstract][Full Text] [Related]
16. Fatty acyl-AMP ligases and polyketide synthases are unique enzymes of lipid biosynthetic machinery in Mycobacterium tuberculosis.
Mohanty D; Sankaranarayanan R; Gokhale RS
Tuberculosis (Edinb); 2011 Sep; 91(5):448-55. PubMed ID: 21601529
[TBL] [Abstract][Full Text] [Related]
17. Multi-omics Investigation into the Mechanism of Action of an Anti-tubercular Fatty Acid Analogue.
Sakallioglu IT; Maroli AS; De Lima Leite A; Marshall DD; Evans BW; Zinniel DK; Dussault PH; Barletta RG; Powers R
J Am Chem Soc; 2022 Nov; 144(46):21157-21173. PubMed ID: 36367461
[TBL] [Abstract][Full Text] [Related]
18. Versatile polyketide enzymatic machinery for the biosynthesis of complex mycobacterial lipids.
Gokhale RS; Saxena P; Chopra T; Mohanty D
Nat Prod Rep; 2007 Apr; 24(2):267-77. PubMed ID: 17389997
[TBL] [Abstract][Full Text] [Related]
19. Drug screening approach against mycobacterial fatty acyl-AMP ligase FAAL32 renews the interest of the salicylanilide pharmacophore in the fight against tuberculosis.
Le NH; Constant P; Tranier S; Nahoum V; Guillet V; Maveyraud L; Daffé M; Mourey L; Verhaeghe P; Marrakchi H
Bioorg Med Chem; 2022 Oct; 71():116938. PubMed ID: 35933838
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for the development of potential inhibitors targeting FadD23 from Mycobacterium tuberculosis.
Yan M; Ma M; Chen R; Cao Y; Zhang W; Liu X
Acta Crystallogr F Struct Biol Commun; 2023 Aug; 79(Pt 8):208-216. PubMed ID: 37522751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
